Charles River Laboratories CRL Cash Flow Statement
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| -$14.8M+94.6% | -$276.29M-597% | $55.56M+5.4% | $52.69M+104% | $25.88M— | ||
| $67.15M-14.2% | $78.28M-8.1% | $85.16M-28.7% | $119.51M-0.7% | $120.36M+17.9% | ||
| $22.38M+26.9% | $17.63M-24.2% | $23.27M+36.5% | $17.05M+29.8% | $13.14M-23.8% | ||
| -$29.42M+51.1% | -$60.17M— | —— | -$21.99M-15.5% | -$19.04M+54.1% | ||
| $15.86M-87.7% | $128.82M+2,486% | $4.98M-75.8% | $20.63M+95.0% | $10.58M-94.6% | ||
| -$117.98M— | —— | —— | —— | $3.38M— | ||
| $47K-96.9% | $1.5M-36.5% | $2.37M+1,187% | $184K-90.8% | $2.01M-69.4% | ||
| $65.32M+336% | -$27.63M-3.9% | -$26.6M-145% | -$10.86M-137% | $29.35M+986% | ||
| -$26M-844% | $3.5M-88.8% | $31.33M— | —— | $21.88M+826% | ||
| $20.46M— | —— | $24.51M— | —— | $25.25M+452% | ||
| -$83.76M— | $0-100% | $42.88M+80.7% | $23.73M+55.5% | $15.26M+160% | ||
| $8.52M— | —— | $43.07M+64.0% | $26.26M+748% | -$4.05M-132% | ||
| $5.2M+120% | -$25.82M-9.3% | -$23.63M-289% | $12.52M+1,132% | -$1.21M-124% | ||
| $41.08M-72.2% | $147.52M-31.0% | $213.83M+4.5% | $204.6M+19.2% | $171.7M+7.7% | ||
| $55.91M-37.1% | $88.95M+150% | $35.58M+0.8% | $35.3M-40.5% | $59.32M-21.5% | ||
| $405.01M— | $0— | $0— | $0— | $0— | ||
| $8.49M+12.7% | $7.53M+69.1% | $4.45M+59.8% | $2.79M-47.4% | $5.3M-30.3% | ||
| $60.1M— | —— | —— | —— | $17.44M— | ||
| -$407.85M-339% | -$92.81M-175% | -$33.7M+9.8% | -$37.34M+17.9% | -$45.48M+40.2% | ||
| $208.29M+216,864% | $96K+3.2% | $93K-98.7% | $7.35M-97.9% | $353.13M+284,684% | ||
| $912.46M+482% | $156.67M+45.7% | $107.5M-80.3% | $547.02M+31.4% | $416.34M+297% | ||
| $355.68M+71.1% | $207.82M-18.1% | $253.79M-65.6% | $738.31M+394% | $149.39M-15.5% | ||
| $1.22M+72.0% | $711K+35,450% | $2K+100% | $1K— | $0-100% | ||
| $347.72M+770% | -$51.86M+66.0% | -$152.62M+32.7% | -$226.92M-115% | -$105.33M-38.8% | ||
| $1.25M-68.2% | $3.93M— | —— | $12.67M+141% | $5.27M+139% | ||
| -$17.8M-363% | $6.78M-72.3% | $24.48M+152% | -$46.99M-280% | $26.16M+531% | ||
| -$117.98M— | —— | —— | —— | $3.38M— | ||
| $15.86M-92.9% | $222.9M+4,374% | $4.98M-75.8% | $20.63M+95.0% | $10.58M-69.3% | ||
| -$135K-101% | $15.19M+1,479% | -$1.1M— | —— | $9.17M— | ||
| -$83.76M— | $0-100% | $42.88M+80.7% | $23.73M+55.5% | $15.26M+160% | ||
| $1.49M-14.8% | $1.75M— | $0-100% | $4.31M-36.3% | $6.76M-75.0% | ||
| $34.68M— | —— | -$1.04M— | —— | -$3.73M+84.7% | ||
| $47K-96.9% | $1.5M-36.5% | $2.37M+1,187% | $184K-90.8% | $2.01M-69.4% | ||
| -$1.14M— | —— | —— | —— | -$10.37M+52.2% | ||
| $1.46M+794% | -$210K+92.5% | -$2.81M-1,055% | -$243K-134% | -$104K+97.9% | ||
| -$2M-49.8% | -$1.34M+78.6% | -$6.23M+3.5% | -$6.46M— | $0+100% | ||
| $355.68M+71.1% | $207.82M-18.1% | $253.79M-65.6% | $738.31M+394% | $149.39M-15.5% | ||
| -$14.83M-125% | $58.57M-67.1% | $178.25M+5.3% | $169.31M+50.7% | $112.37M+34.2% | ||
| -$14.83M-125% | $58.57M-67.1% | $178.25M+5.3% | $169.31M+50.7% | $112.37M+34.2% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How much cash does Charles River Laboratories generate?
- Charles River Laboratories (CRL) generated $607.0M in operating cash flow over the trailing twelve months.
- What is Charles River Laboratories's free cash flow?
- After $215.7M of capital expenditures, Charles River Laboratories's free cash flow was $391.3M over the trailing twelve months, down 30.5% year over year.
- Where does Charles River Laboratories's cash flow data come from?
- Every line is extracted from Charles River Laboratories's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
